NASDAQ : STLN
Starling Oncology, Inc. — Financial statements
Healthcare · Medical Care Facilities · United States
Last price 6.65 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 677.74M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Starling Oncology, Inc. (STLN) reported revenue of 587.24M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 587.24M | 502.73M | 393.41M | 324.24M | 252.48M | 203.00M |
| Cost of Revenue | 495.08M | 426.29M | 339.42M | 264.67M | 200.39M | 162.16M |
| Gross Profit | 92.17M | 76.44M | 54.00M | 59.57M | 52.09M | 40.85M |
| Selling, General & Admin | 111.45M | 105.57M | 107.83M | 113.85M | 119.69M | 82.89M |
| Operating Expenses | 118.25M | 112.52M | 114.11M | 119.72M | 124.10M | 86.23M |
| Operating Income | -26.09M | -36.08M | -60.12M | -60.15M | -72.01M | -45.38M |
| Interest Expense | -7.63M | -11.28M | -7.50M | -6.78M | -4.08M | -320.00K |
| Other Non Operating Income (Expenses) | -2.59M | -13.38M | 2.82M | -349.00K | 25.90M | 3.71M |
| EBT Excluding Unusual Items | -36.30M | -60.74M | -64.80M | -67.28M | -50.19M | -41.99M |
| Merger & Restructuring Charges | -476.00K | |||||
| Impairment of Goodwill | -16.87M | -9.94M | ||||
| Gain (Loss) on Sale of Investments | 12.00K | 6.00K | 133.00K | 237.00K | 640.00K | |
| Other Unusual Items | 803.00K | 59.40M | 30.87M | |||
| Pretax Income | -36.29M | -60.74M | -64.66M | -83.10M | -91.00K | -11.60M |
| Income Tax Expense | -131.00K | -36.00K | -243.00K | -671.00K | ||
| Net Income | -36.29M | -60.61M | -64.66M | -83.07M | 152.00K | -10.93M |
| Preferred Dividends & Other Adjustments | -5.73M | -10.30M | -11.66M | -15.19M | 84.00K | -299.00K |
| Net Income to Common | -30.56M | -50.30M | -53.01M | -67.88M | 68.00K | -10.63M |
| Shares Outstanding (Basic) | 101.00M | 92.39M | 75.04M | 73.75M | 72.79M | 66.23M |
| Shares Outstanding (Diluted) | 101.00M | 92.39M | 75.04M | 73.75M | 80.61M | 66.23M |
| EPS (Basic) | -0.30 | -0.54 | -0.71 | -0.92 | 0.00 | -0.16 |
| EPS (Diluted) | -0.30 | -0.54 | -0.71 | -0.92 | -0.21 | -0.16 |
| Free Cash Flow | -3.29M | -27.79M | -30.33M | -40.88M | -67.28M | -35.53M |
| Free Cash Flow Per Share | -0.03 | -0.30 | -0.40 | -0.55 | -0.83 | -0.54 |
| Gross Margin | 15.69% | 15.20% | 13.73% | 18.37% | 20.63% | 20.12% |
| Operating Margin | -4.44% | -7.18% | -15.28% | -18.55% | -28.52% | -22.36% |
| Profit Margin | -5.20% | -10.01% | -13.47% | -20.93% | 0.03% | -5.24% |
| Free Cash Flow Margin | -0.56% | -5.53% | -7.71% | -12.61% | -26.65% | -17.50% |
| EBITDA | -19.28M | -29.14M | -53.83M | -54.28M | -67.60M | -42.04M |
| EBITDA Margin | -3.28% | -5.80% | -13.68% | -16.74% | -26.77% | -20.71% |
| D&A For EBITDA | 6.81M | 6.94M | 6.29M | 5.87M | 4.41M | 3.34M |
| EBIT | -26.09M | -36.08M | -60.12M | -60.15M | -72.01M | -45.38M |
| EBIT Margin | -4.44% | -7.18% | -15.28% | -18.55% | -28.52% | -22.36% |
| Revenue as Reported | 587.24M | 502.73M | 393.41M | 324.24M | 252.48M | 203.00M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 41.09M | 33.56M | 49.67M | 33.49M | 14.01M | 114.30M |
| Short-Term Investments | 49.37M | 59.80M | ||||
| Cash & Short-Term Investments | 41.09M | 33.56M | 49.67M | 82.86M | 73.81M | 114.30M |
| Accounts Receivable | 66.35M | 59.00M | 48.34M | 42.36M | 39.82M | 20.01M |
| Other Receivables | 360.00K | 322.00K | 346.00K | 551.00K | 617.00K | 1.24M |
| Receivables | 66.71M | 59.32M | 48.68M | 42.91M | 40.43M | 21.24M |
| Inventory | 20.01M | 16.88M | 10.04M | 13.68M | 9.26M | 6.44M |
| Prepaid Expenses | 1.18M | 2.99M | 4.03M | 4.05M | 6.92M | 11.20M |
| Restricted Cash | 875.00K | |||||
| Total Current Assets | 128.99M | 112.75M | 112.42M | 143.49M | 130.42M | 154.06M |
| Property, Plant & Equipment | 31.77M | 33.06M | 37.67M | 40.05M | 33.04M | 4.19M |
| Long-Term Investments | 58.35M | |||||
| Goodwill | 7.23M | 7.23M | 7.23M | 7.23M | 21.42M | 26.63M |
| Other Intangible Assets | 9.59M | 11.02M | 14.81M | 17.90M | 17.96M | 18.25M |
| Other Long-Term Assets | 657.00K | 606.00K | 589.00K | 561.00K | 477.00K | 320.00K |
| Total Assets | 178.23M | 164.66M | 172.72M | 209.24M | 261.67M | 203.44M |
| Accounts Payable | 60.28M | 43.17M | 24.32M | 14.43M | 9.37M | 15.56M |
| Accrued Expenses | 20.58M | 11.50M | 9.28M | 10.70M | 9.42M | 8.33M |
| Short-Term Debt | 270.00K | 794.00K | 770.00K | |||
| Current Portion of Long-Term Debt | 183.00K | |||||
| Current Portion of Leases | 7.26M | 7.19M | 6.80M | 6.36M | 5.50M | |
| Current Income Taxes Payable | 255.00K | 132.00K | ||||
| Current Unearned Revenue | 2.28M | 2.35M | 1.09M | 1.14M | 262.00K | |
| Other Current Liabilities | 6.55M | 6.02M | 8.69M | 2.21M | 4.04M | 5.33M |
| Total Current Liabilities | 94.94M | 70.96M | 52.22M | 34.79M | 29.72M | 29.80M |
| Long-Term Debt | 79.87M | 77.40M | 93.13M | 86.83M | 80.62M | |
| Long-Term Leases | 17.39M | 19.16M | 23.22M | 26.49M | 22.06M | |
| Long-Term Deferred Tax Liabilities | 32.00K | 32.00K | 108.00K | 371.00K | ||
| Other Long-Term Liabilities | 10.95M | 12.86M | 527.00K | 4.08M | 5.98M | 69.11M |
| Total Liabilities | 203.15M | 180.38M | 169.13M | 152.22M | 138.49M | 99.28M |
| Common Stock | 10.00K | 10.00K | 8.00K | 8.00K | 7.00K | 7.00K |
| Additional Paid-In Capital | 259.80M | 256.71M | 215.41M | 204.19M | 186.25M | 167.39M |
| Retained Earnings | -283.70M | -271.42M | -210.81M | -146.15M | -63.08M | -63.23M |
| Treasury Stock | -1.02M | -1.02M | -1.02M | -1.02M | ||
| Total Common Equity | -24.91M | -15.72M | 3.59M | 57.02M | 123.17M | 104.16M |
| Shareholders' Equity | -24.91M | -15.72M | 3.59M | 57.02M | 123.17M | 104.16M |
| Total Liabilities & Equity | 178.23M | 164.66M | 172.72M | 209.24M | 261.67M | 203.44M |
| Total Debt | 104.79M | 104.55M | 123.92M | 119.67M | 108.18M | 183.00K |
| Net Cash (Debt) | -63.70M | -70.98M | -74.25M | -36.82M | -34.37M | 114.12M |
| Net Cash Per Share | -0.63 | -0.77 | -0.99 | -0.50 | -0.43 | 1.72 |
| Filing Date Shares Outstanding | 101.92M | 98.84M | 75.75M | 74.31M | 74.55M | 73.25M |
| Total Common Shares Outstanding | 100.47M | 98.86M | 75.74M | 74.15M | 73.27M | 73.25M |
| Working Capital | 34.05M | 41.78M | 60.20M | 108.70M | 100.70M | 124.26M |
| Book Value Per Share | -0.25 | -0.16 | 0.05 | 0.77 | 1.68 | 1.42 |
| Tangible Book Value | -41.73M | -33.97M | -18.45M | 31.89M | 83.80M | 59.29M |
| Tangible Book Value Per Share | -0.42 | -0.34 | -0.24 | 0.43 | 1.14 | 0.81 |
| Machinery | 9.47M | 7.42M | 6.04M | 5.84M | 3.88M | 2.11M |
| Construction In Progress | 556.00K | 1.14M | 106.00K | 1.80M | 1.14M | 518.00K |
| Leasehold Improvements | 13.25M | 12.85M | 12.50M | 9.21M | 6.66M | 3.39M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -36.29M | -60.61M | -64.66M | -83.07M | 152.00K | -10.93M |
| Depreciation & Amortization | 6.81M | 6.94M | 6.29M | 5.87M | 4.41M | 3.34M |
| Other Amortization | 4.84M | 8.38M | 6.30M | 6.21M | 2.44M | 53.00K |
| Loss (Gain) From Sale of Assets | 28.00K | 271.00K | -30.00K | 21.00K | ||
| Asset Writedown & Restructuring Costs | 2.40M | 16.87M | 9.94M | |||
| Loss (Gain) From Sale of Investments | -633.00K | -2.88M | -642.00K | |||
| Stock-Based Compensation | 5.10M | 4.55M | 11.15M | 17.81M | 27.68M | 24.54M |
| Provision & Write-off of Bad Debts | 2.02M | 476.00K | -417.00K | |||
| Other Operating Activities | 3.13M | 12.42M | -3.32M | -1.47M | -85.70M | -34.78M |
| Change in Accounts Receivable | -10.69M | -12.31M | -5.97M | -4.56M | -20.29M | -2.19M |
| Change in Inventory | -4.22M | -6.84M | 3.64M | -4.38M | -1.73M | -1.84M |
| Change in Accounts Payable | 25.26M | 19.64M | 9.21M | 5.06M | -6.19M | 2.92M |
| Change in Income Taxes | -255.00K | 123.00K | -1.01M | |||
| Change in Other Net Operating Assets | 6.36M | 831.00K | 11.18M | 6.51M | 7.54M | -12.36M |
| Operating Cash Flow | 328.00K | -24.59M | -26.54M | -36.31M | -61.76M | -32.68M |
| Capital Expenditures | -3.61M | -3.20M | -3.79M | -4.57M | -5.53M | -2.85M |
| Sale of Property, Plant & Equipment | 126.00K | |||||
| Cash Acquisitions | -4.46M | -8.58M | -9.11M | |||
| Sale (Purchase) of Intangibles | -200.00K | |||||
| Investment in Securities | 50.00M | 71.66M | -117.51M | |||
| Investing Cash Flow | -3.61M | -3.07M | 46.21M | 62.64M | -131.61M | -12.15M |
| Long-Term Debt Issued | 110.00M | 8.43M | ||||
| Long-Term Debt Repaid | -21.03M | -1.20M | -3.37M | -5.07M | -7.66M | |
| Net Debt Issued (Repaid) | -1.13M | -21.03M | -1.20M | -3.37M | 104.93M | 769.00K |
| Issuance of Common Stock | 15.27M | 32.63M | 75.00K | 126.00K | 858.00K | |
| Repurchase of Common Stock | -1.02M | -9.41M | ||||
| Other Financing Activities | -50.00K | -50.00K | -2.37M | -2.58M | -4.17M | 133.24M |
| Financing Cash Flow | 14.09M | 11.56M | -3.49M | -6.85M | 92.21M | 154.01M |
| Net Cash Flow | 10.80M | -16.10M | 16.18M | 19.48M | -101.16M | 109.18M |
| Free Cash Flow | -3.29M | -27.79M | -30.33M | -40.88M | -67.28M | -35.53M |
| Free Cash Flow Margin | -0.56% | -5.53% | -7.71% | -12.61% | -26.65% | -17.50% |
| Free Cash Flow Per Share | -0.03 | -0.30 | -0.40 | -0.55 | -0.83 | -0.54 |
| Levered Free Cash Flow | 8.60M | -11.03M | -8.19M | -16.33M | -40.79M | -13.34M |
| Unlevered Free Cash Flow | 8.52M | -12.36M | -9.81M | -18.30M | -40.69M | -13.19M |
| Cash Interest Paid | 3.51M | 3.91M | 4.50M | 4.51M | 224.00K | 275.00K |
| Cash Income Tax Paid | 403.00K | 150.00K | 1.73M | |||
| Change in Working Capital | 16.71M | 1.32M | 18.06M | 2.36M | -20.54M | -14.49M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 665.51M | 350.24M | 23.35M | 150.45M | 122.80M | 714.18M |
| Enterprise Value | 729.21M | 426.20M | 99.01M | 180.53M | 138.54M | 807.66M |
| Last Close Price | 6.53 | 3.56 | 0.31 | 2.04 | 1.65 | 9.75 |
| PE Ratio | 1,805.81 | |||||
| PS Ratio | 1.13 | 0.70 | 0.06 | 0.46 | 0.49 | 3.52 |
| PB Ratio | -22.28 | 6.50 | 2.64 | 1.00 | 6.86 | |
| P/TBV Ratio | 4.72 | 1.47 | 12.05 | |||
| EV/Sales Ratio | 1.24 | 0.85 | 0.25 | 0.56 | 0.55 | 3.98 |
| Debt / Equity Ratio | -4.21 | -6.65 | 34.53 | 2.10 | 0.88 | 0.00 |
| Net Debt / Equity Ratio | -2.56 | -4.51 | 20.69 | 0.65 | 0.28 | -1.10 |
| Net Debt / EBITDA Ratio | -3.30 | -2.44 | -1.38 | -0.68 | -0.51 | 2.71 |
| Net Debt / FCF Ratio | -19.39 | -2.55 | -2.45 | -0.90 | -0.51 | 3.21 |
| Asset Turnover | 3.47 | 2.98 | 2.06 | 1.38 | 1.09 | 1.51 |
| Inventory Turnover | 27.66 | 31.68 | 28.62 | 23.08 | 25.53 | 30.05 |
| Quick Ratio | 1.14 | 1.31 | 1.88 | 3.62 | 3.84 | 4.55 |
| Current Ratio | 1.36 | 1.59 | 2.15 | 4.12 | 4.39 | 5.17 |
| Return on Equity (ROE) | -213.36% | -92.20% | 0.13% | -16.52% | ||
| Return on Assets (ROA) | -9.65% | -13.37% | -19.67% | -15.97% | -19.35% | -21.08% |
| Return on Invested Capital (ROIC) | -30.31% | -42.07% | -70.03% | -47.85% | -45.70% | |
| Return on Capital Employed (ROCE) | -31.30% | -38.50% | -49.90% | -34.50% | -31.00% | -26.10% |
| Earnings Yield | -4.66% | -17.30% | -276.96% | -55.21% | 0.12% | -1.53% |
| FCF Yield | -0.49% | -7.93% | -129.89% | -27.17% | -54.80% | -4.98% |
| Buyback Yield / Dilution | -25.63% | -23.11% | -1.76% | 8.51% | -21.70% | -12.03% |